PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Cell and Gene Therapy

Upcoming Events

Cell 2025 – 30.05.2025
Cell Leaders Awards – 30.05.2025
Biotechnology Show 2025: 20th January 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025
news

RNA Editing: Emerging from CRISPR’s Shadow

Early study data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such results are just the start. Thor...
Continue Reading →
news

Aftershocks for Lilly, CRISPR versus CRISPR and Bluebird’s crucial year

The biggest industry news of the week came not from the J.P. Morgan Healthcare Conference or any associated announcements, but from Washington, D.C, where the Centers...
Continue Reading →
news

Vertex aligns with another CRISPR gene editing startup

Mammoth's evolution into a drugmaker appears to be paying off. Three years ago, the company formed with a plan to use CRISPR gene editing to detect and diagnose dise...
Continue Reading →
news

Lilly joins RNA editing race with ProQR deal

Much of the attention in the genetic editing world in recent years has been on CRISPR and the "genetic scissors" that allow researchers to make targeted changes to DN...
Continue Reading →
Volume 4 Issue 3

CRISPR-Cas9 Knockout Screening Using Primary Human Cells in Drug Discovery

While significant progress has been made carrying out CRISPR screens in immortalised cell lines, a more physiological and clinically relevant alternative is human pri...
Continue Reading →
news

Vertex, CRISPR gene-editing therapy hit with clinical hold

U.S. regulators have placed a clinical hold on CRISPR Therapeutics' lead candidate, spurring a double-digit drop in the Swiss biotech's stock value by Thursday mo...
Continue Reading →
Newcells 3 June 2024, 15:12
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
Tosoh – 29.04.25
Eppendorf – 18.03.2025
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025